
dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.
dsm-firmenich announced a strong Q3 2026 trading update with 5% like-for-like sales growth and an improved Adjusted EBITDA margin of 20.4%. The company’s performance was driven by volume growth across its three business units: Perfumery & Beauty, Tas...





